Blue Light and Melatonin: What the Latest Evidence Tells Clinicians About Screens, Circadian Rhythm, and Blue Light Blockers

Melatonin secretion from the pineal gland is gated by the suprachiasmatic nucleus (SCN), which receives light information not primarily from rods and cones but from intrinsically photosensitive retinal ganglion cells (ipRGCs). These cells express melanopsin, a photopigment maximally sensitive to short-wavelength light near 480 nm. When blue-enriched light reaches the retina in the biological evening, ipRGC signaling to the SCN suppresses melatonin, delays circadian phase, and increases sleep onset latency.^[2] This is why the blue light circadian rhythm relationship is dose-, wavelength-, and time-dependent rather than a simple on/off effect.

A 2025 controlled comparison in healthy adults illustrates the wavelength dependence directly: after two hours of evening exposure, salivary melatonin remained suppressed at roughly 7.5 pg/mL under blue LED light, while participants exposed to red light recovered to about 26.0 pg/mL — a threefold difference from an otherwise matched light source.^[5]

The conversation usually centers on phones and tablets, but ambient room lighting delivers a substantial, sustained dose. A 2025 Scientific Reports characterization of 52 consumer lamps quantified each bulb's Melatonin Suppression Value (MSV). "Cool white" LED lamps produced a median MSV of 12.3% and cool-white CFLs 12.1% — roughly three to eight times higher than "warm white" LED (3.6%), warm-white CFL (2.6%), and incandescent (1.5%) sources.^[1] The authors note real-world living spaces layering multiple fixtures can push cumulative suppression far higher.

This is where practitioners must be precise. A 2025 systematic review and meta-analysis in Frontiers in Neurology pooled three double-blind randomized crossover trials (n = 49) measuring actigraphic outcomes in adults wearing blue light blocking glasses before bed. The pooled effect on sleep onset latency was a mean difference of −4.86 minutes (95% CI −20.23 to 10.52; p = 0.54), with low heterogeneity (I² = 0%).^[3] In plain terms: the point estimate favors the glasses, but the confidence interval crosses zero, so the objective effect on general adult sleep onset is not statistically established.

That null-leaning result should be interpreted alongside two things. First, the trials were small and used objective actigraphy, which is less sensitive to circadian phase than melatonin timing. Second, effects appear larger where blue-light exposure or circadian vulnerability is higher. A double-blind RCT in third-trimester pregnant women found true blue-blocking glasses advanced melatonin onset by about 28 minutes versus partial blockers^[6] — a circadian phase signal that actigraphic sleep-onset pooling can miss.

A 2025 randomized crossover study in adolescent athletes (Biology of Sport) exposed intermediate-chronotype participants to blue light in four evening windows. Total sleep duration was markedly shorter, and dart-throwing accuracy significantly worse, when exposure occurred from 9:00 PM onward compared with a 7:30–9:00 PM window or no exposure — the same light, later, produced worse sleep and next-day motor performance.^[4] For children and adolescents, whose lenses transmit more short-wavelength light and whose melatonin systems appear more light-sensitive, this reinforces earlier device curfews as the higher-yield intervention.